Market Access

HTAnalyze delivers Value, Evidence & Outcomes (VEO) solutions for market access and pricing, integrating clinical evidence, HEOR, budget impact, and RWE. In addition to our established presence in Brazil, we are equipped to technically support regulatory submissions and incorporation processes in jurisdictions across Latin America, Europe, and North America.

Market Access – Global

Global Value Dossier (GVD)

HTAnalyze’s Global Value Dossier integrates clinical evidence synthesis, economic value drivers, and positioning strategy into a modular package for international HTA, market access, and reimbursement discussions.

Get in touch

Budget Impact Analysis (BIA)

We develop decision-oriented budget impact models, including target population estimates, adoption scenarios, technology diffusion assumptions, and healthcare system costs, tailored to jurisdictions across Latin America, North America, and Europe.

Get in touch

Health Economic Modeling

We develop and adapt health economic models, including Markov models, partitioned survival models, microsimulations, and decision trees, for cost-effectiveness and cost-utility analyses supporting incorporation, reimbursement, and pricing decisions across Latin America, North America, and Europe.

Get in touch